Envista Holdings Co. (NYSE:NVST) Shares Sold by North Star Asset Management Inc.

North Star Asset Management Inc. lessened its holdings in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 85.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,229 shares of the company's stock after selling 129,413 shares during the quarter. North Star Asset Management Inc.'s holdings in Envista were worth $535,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Raymond James & Associates boosted its position in shares of Envista by 820.6% during the 4th quarter. Raymond James & Associates now owns 408,218 shares of the company's stock valued at $9,822,000 after acquiring an additional 363,875 shares during the last quarter. River Road Asset Management LLC acquired a new position in shares of Envista during the 4th quarter valued at about $54,931,000. Blueshift Asset Management LLC boosted its position in shares of Envista by 168.7% during the 3rd quarter. Blueshift Asset Management LLC now owns 41,524 shares of the company's stock valued at $1,158,000 after acquiring an additional 26,073 shares during the last quarter. Algert Global LLC acquired a new position in shares of Envista during the 3rd quarter valued at about $748,000. Finally, DAVENPORT & Co LLC acquired a new position in shares of Envista during the 4th quarter valued at about $13,233,000.

Envista Stock Up 0.9 %

Shares of NVST stock traded up $0.17 during trading hours on Monday, reaching $20.13. 1,590,770 shares of the stock were exchanged, compared to its average volume of 2,351,168. The business's fifty day moving average is $21.17 and its two-hundred day moving average is $22.87. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.23 and a quick ratio of 1.90. Envista Holdings Co. has a 12-month low of $18.95 and a 12-month high of $39.28. The firm has a market capitalization of $3.46 billion, a P/E ratio of -33.00, a P/E/G ratio of 3.73 and a beta of 1.35.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.29 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by ($0.04). The business had revenue of $645.60 million during the quarter, compared to analyst estimates of $638.37 million. Envista had a negative net margin of 3.90% and a positive return on equity of 6.31%. The business's revenue for the quarter was down 2.3% compared to the same quarter last year. During the same period last year, the company earned $0.52 earnings per share. As a group, research analysts expect that Envista Holdings Co. will post 1.43 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Leerink Partnrs restated an "underperform" rating on shares of Envista in a report on Monday, February 26th. UBS Group assumed coverage on shares of Envista in a report on Friday, January 5th. They issued a "neutral" rating and a $26.00 price objective on the stock. Jefferies Financial Group lowered shares of Envista from a "buy" rating to a "hold" rating and reduced their price objective for the company from $30.00 to $23.00 in a report on Friday, February 9th. William Blair lowered shares of Envista from an "outperform" rating to a "market perform" rating in a report on Thursday, February 8th. Finally, SVB Leerink started coverage on shares of Envista in a report on Monday, February 26th. They issued an "underperform" rating and a $19.00 price objective on the stock. Three analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Envista has an average rating of "Hold" and a consensus price target of $29.60.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.